Negative effect of hepatitis in overall and progression-free survival among patients with diffuse large B-cell lymphoma

BACKGROUND: Hepatitis B virus (HBV) is one of the most prevalent and serious infections worldwide. HBV reactivation is a serious complication for lymphoma patients who are being treated with rituximab-containing regimen. Since the impact of HBV has not been fully evaluated on the prognosis of diffus...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Mansour, Mubarak M., Alghamdi, Saif A., Alsubaie, Musab A., Alesa, Abdullah A., Khan, Muhammad A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992760/
https://www.ncbi.nlm.nih.gov/pubmed/29977329
http://dx.doi.org/10.1186/s13027-018-0190-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992760/
https://www.ncbi.nlm.nih.gov/pubmed/29977329
http://dx.doi.org/10.1186/s13027-018-0190-9

Ejemplares similares